Home example 2 - Pharmamarketeer

technologie

Gilead signs deal with Nurix Therapeutics worth more than $2.3 billion

Gilead has signed a deal with San Francisco biotech Nurix Therapeutics – a company focused on developing drugs that control levels of the enzyme ubiquitin E3 ligases which are responsible for the breakdown of proteins...

InPharm.com

7 x gelezen

onderzoek

Generation of three-dimensional heart organoids

Three-dimensional heart organoids Researchers from Tokyo Medical and Dental University (TMDU) engineered three-dimensional functional heart organoids resembling the developing heart. By exposing mouse embryonic stem...

EurekAlert

7 x gelezen

onderzoek

WHO trial casts doubt on remdesivir’s efficacy

Remdesivir
Drug’s developer Gilead hits back at the findings

PMLiVE

7 x gelezen

wet- en regelgeving

US FDA approves Abbotts new ablation catheter, TactiCath SE to help physicians accurately treat patients with atrial fibrillation

Abbott announced US Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter designed to help physicians accurately and effectively

Pharma Biz

7 x gelezen

marketing

Infographic: Most seniors delay care after noticing symptoms

Seniors delay care The Mesothelioma Center surveyed seniors about seeking care. The survey reached more than 1,000 adults over 65 and asked how long they wait before visiting the doctor after noticing symptoms and the...

MMM - Medical Marketing and Media

7 x gelezen

onderzoek

NIH awards $31 million grants to study wide range of rare diseases

Of an estimated 6,500 to 7,000 known rare diseases, only a fraction – maybe 5% – have US Food and Drug Administration─approved treatments. To increase that percentage, the National Institutes of Health

Pharma Biz

7 x gelezen

technologie

Samen schrijven met een robot? Deze 4 AI-tools helpen je op weg

Het schrijven van teksten is een zeer complexe en ingewikkelde taak, zeker wanneer je het liefst zo efficiënt mogelijk te werk gaat. Het is immers niet gemakkelijk om aan de lopende band teksten te produceren die aan...

Frankwatching.nl

7 x gelezen

marketing

Hoe het versturen van minder e-mails en content previews de nieuwsbriefbetrokkenheid van The New Yorker verbeterde

De nieuwsbriefbetrokkenheid van The New Yorker verbeterde The New Yorker heeft zijn nieuwsbriefstrategie herzien om zijn groep van 1,2 miljoen betalende abonnees te behouden en zijn publiek daarbuiten te laten groeien...

digiday.com

7 x gelezen

wet- en regelgeving

Edwards Lifesciences receives US FDA approval for SAPIEN 3 Ultra transcatheter heart valve

Edwards Lifesciences Corporation, the global leader in patient─focused innovations for structural heart disease and critical care monitoring, announced that the SAPIEN 3 Ultra system has received US Food and Drug...

Pharma Biz

7 x gelezen

Latest articles

Gilead signs deal with Nurix Therapeutics worth more than $2.3 billion

Generation of three-dimensional heart organoids

WHO trial casts doubt on remdesivir’s efficacy

US FDA approves Abbotts new ablation catheter, TactiCath SE to help physicians accurately treat patients with atrial fibrillation

Top 13 internationale contentmarketing cases (deel 1)

Infographic: Most seniors delay care after noticing symptoms

NIH awards $31 million grants to study wide range of rare diseases

Samen schrijven met een robot? Deze 4 AI-tools helpen je op weg

Hoe het versturen van minder e-mails en content previews de nieuwsbriefbetrokkenheid van The New Yorker verbeterde

Edwards Lifesciences receives US FDA approval for SAPIEN 3 Ultra transcatheter heart valve

Wekelijkse highlights per e-mail

Algemene informatie